Saturday 17 October 2026
Export MASS’s income statement to Excel — free account
908 Devices Inc.
MASS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.
11.33
0.56
−4.71%
Follow MASS
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 6 | 3 | 3 | 3 | 4 | 5 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.38 |
Altman Z-Score |
— | — | — | 5.21 | 9.81 | 2.68 | 5.06 | (1.43) | 1.10 |
P/S ratio |
— | 8.30 | 8.30 | 14.70 | 17.14 | 4.93 | 6.37 | 1.57 | 3.35 |
Altman Z″-Score (non-manufacturers) |
— | — | (4.58) | 7.89 | 9.03 | 6.38 | 5.37 | (1.50) | 1.84 |
P/FCF ratio |
— | 0.00 | 0.00 | 95.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | 1.04 | (2.73) | (1.52) | (1.94) | (2.59) | (2.67) | (2.52) |
P/Operating CF |
— | 29.89 | 29.89 | 169.53 | (78.45) | (45.18) | (165.71) | (33.42) | 142.89 |
P/B ratio |
— | 0.00 | 0.00 | 2.84 | 3.37 | 1.21 | 1.93 | 0.65 | 1.31 |
Price to Tangible BV |
— | 0.00 | 0.00 | 2.84 | 3.37 | 1.34 | 2.17 | 0.99 | 1.76 |
EV/Sales |
— | 8.38 | 8.38 | 9.33 | 12.20 | 1.24 | 3.78 | 0.45 | 1.62 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (26.87) | (26.87) | 60.75 | (17.70) | (2.78) | (7.57) | (0.71) | (3.84) |
EV/FCF |
— | (25.75) | (25.75) | 60.88 | (17.26) | (2.53) | (7.00) | (0.70) | (3.69) |
Quick Ratio |
— | 2.82 | 3.80 | 15.33 | 16.21 | 10.32 | 6.86 | 3.09 | 3.65 |
Current Ratio |
— | 3.61 | 4.72 | 15.78 | 17.05 | 11.22 | 7.71 | 4.10 | 4.24 |
Net Debt/EBITDA |
— | (1.96) | 0.18 | 28.97 | 9.89 | 5.14 | 3.58 | 5.73 | 3.17 |
Debt/Assets |
0.00% | 64.63% | 42.08% | 8.29% | 5.75% | 6.18% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 6.16 | (0.25) | 0.11 | 0.07 | 0.08 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 1.59 | 0.55 | 0.25 | 0.19 | 0.19 | 0.23 | 0.26 | 0.32 |
Operating CF/Net income |
— | 1.17 | 0.82 | (0.32) | 1.31 | 0.62 | 0.69 | 0.42 | (1.22) |
Capex/Depreciation |
— | 0.00 | (0.44) | (0.01) | (0.80) | (1.27) | (0.98) | (0.01) | (0.25) |
Interest Coverage |
— | (10.33) | (7.94) | (5.96) | (45.41) | (274.28) | (212.73) | — | — |
| — | 13.43% | 23.79% | (34.03%) | (12.54%) | (16.57%) | (20.44%) | (51.56%) | 15.09% | |
| — | (54.87%) | (41.22%) | (11.93%) | (10.08%) | (13.33%) | (16.34%) | (39.84%) | 11.15% | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (249.38%) | (128.74%) | (134.91%) | (78.54%) | (80.18%) |
Return on Tangible Assets |
— | (33.89%) | (56.52%) | (8.02%) | (9.25%) | (16.82%) | (23.55%) | (90.82%) | 16.99% |
Average Days of Receivables |
— | 104.86 | 103.15 | 92.63 | 141.61 | 78.16 | 65.32 | 67.67 | 73.57 |
Research and Development Expense of Revenue |
— | 43.20% | 50.04% | 30.62% | 30.96% | 37.41% | 43.61% | 31.39% | 27.72% |
Selling, General and Administrative Expense of Revenue |
— | 42.19% | 62.84% | 46.49% | 76.38% | 93.65% | 91.72% | 82.65% | 68.56% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.09 | 0.24 | 0.19 |
Share Based Compensation of Revenue |
— | 0.00% | 1.49% | 1.95% | 5.93% | 15.38% | 19.48% | 24.64% | 17.52% |
Graham Net Nets |
— | 0.14 | 0.14 | 0.33 | 0.29 | 0.71 | 0.43 | 0.78 | 0.52 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.10 |
Earnings Yield |
— | (1.10%) | (1.10%) | (3.51%) | (3.09%) | (14.58%) | (11.39%) | (95.45%) | 10.67% |
Free Cash Flow Yield |
— | (3.92%) | (3.92%) | 1.04% | (4.12%) | (9.94%) | (8.48%) | (41.15%) | (13.08%) |
Revenue per Share |
— | 0.84 | 3.60 | 4.90 | 1.51 | 1.49 | 1.56 | 1.40 | 1.57 |
Operating CF per Share |
— | (0.34) | (2.21) | 0.75 | (1.04) | (0.66) | (0.78) | (0.89) | (0.66) |
Capex per Share |
— | 0.00 | (0.08) | 0.00 | (0.03) | (0.06) | (0.06) | (0.02) | (0.03) |
Free Cash Flow per Share |
— | (0.34) | (2.28) | 0.75 | (1.07) | (0.73) | (0.84) | (0.91) | (0.69) |
Cash per Share |
— | 0.27 | 3.59 | 29.03 | 8.01 | 5.98 | 4.52 | 2.02 | 3.15 |
Shareholders Equity per Share |
— | 0.11 | (12.66) | 25.35 | 7.68 | 6.05 | 5.13 | 3.36 | 4.00 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.11 | (12.66) | 25.35 | 7.68 | 6.05 | 5.13 | 3.36 | 4.00 |
Free Cash Flow |
— | (8.90) | (11.40) | 4.12 | (29.82) | (22.97) | (27.10) | (30.85) | (24.64) |
Working Capital |
— | 12.44 | 22.53 | 160.13 | 238.06 | 196.40 | 151.24 | 77.91 | 110.50 |
Capital Expenditures |
— | (0.73) | (0.39) | (0.01) | (0.74) | (2.04) | (2.04) | (0.60) | (0.95) |
Net Current Asset Value |
— | (7.63) | (72.25) | 131.18 | 206.59 | 163.64 | 136.30 | 58.17 | 98.19 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.02 | 0.00 | 0.02 | 0.04 | 0.04 | 0.01 | 0.02 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.09 | 0.68 | 0.98 | 0.58 | 0.52 | 0.62 | 28.44 | 0.90 |
Cash ROIC |
— | (31.87%) | 38.75% | 1.32% | (6.57%) | (5.83%) | (8.71%) | (16.81%) | (9.60%) |
Accounts Receivable Turnover |
— | 3.86 | 3.15 | 4.52 | 3.64 | 3.55 | 5.28 | 5.35 | 5.57 |
Accounts Payable Turnover |
— | 15.81 | 16.09 | 15.14 | 15.98 | 15.05 | 19.25 | 18.17 | 18.80 |
Inventory Turnover |
— | 2.21 | 2.24 | 2.44 | 3.04 | 2.04 | 1.81 | 1.80 | 2.33 |
Average Days of Payables |
— | 24.37 | 21.43 | 30.61 | 26.38 | 24.48 | 17.45 | 21.48 | 20.84 |
Days of Inventory on Hand |
— | 133.10 | 194.48 | 139.28 | 152.33 | 219.27 | 218.91 | 170.93 | 170.71 |
Average Receivables |
— | 5.71 | 5.71 | 5.95 | 11.60 | 13.20 | 9.51 | 8.92 | 10.09 |
Average Payables |
— | 0.61 | 0.61 | 0.79 | 1.19 | 1.38 | 1.29 | 1.28 | 1.48 |
Average Inventory |
— | 4.38 | 4.38 | 4.90 | 6.24 | 10.22 | 13.73 | 12.91 | 11.94 |
Average Assets |
— | 13.87 | 32.71 | 108.24 | 219.87 | 251.75 | 222.78 | 181.23 | 174.77 |
Average Common Equity |
— | (56.67) | (56.67) | 37.94 | 176.82 | 202.60 | 178.05 | 140.04 | 129.15 |
Columns are period end dates